Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer

Yervoy (ipilimumab) - BMS

paclitaxel - Generic mfg.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

methotrexate - Generic mfg.

carboplatin - Generic mfg.

Keytruda (pembrolizumab) - Merck (MSD)

Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer (clinicaltrials.gov) - Oct 24, 2026 - P1 | N=20 | Not yet recruiting | Sponsor: Oliver Jonas
New P1 trial • Lung Cancer • Mesothelioma • Oncology • Solid Tumor

http://clinicaltrials.gov/ct2/show/NCT07892300

Oct 24, 2026